 | • レポートコード：QYR2104Z5232 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、鎌状赤血球症治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（予防接種＆抗生物質による感染予防、輸血、ヒドロキシカルバミド薬、骨髄細胞移植）、用途別市場規模（病院、外来手術センター、診療所、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・鎌状赤血球症治療の市場動向 ・企業の競争状況、市場シェア ・鎌状赤血球症治療の種類別市場規模（予防接種＆抗生物質による感染予防、輸血、ヒドロキシカルバミド薬、骨髄細胞移植） ・鎌状赤血球症治療の用途別市場規模（病院、外来手術センター、診療所、その他） ・鎌状赤血球症治療の北米市場規模2016-2027（アメリカ、カナダ） ・鎌状赤血球症治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・鎌状赤血球症治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・鎌状赤血球症治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・鎌状赤血球症治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AstraZeneca、Eli Lilly、Bristol-Myers Squibb、Novartis、Pfizer、Baxter、Emmaus Life Sciences、Bluebird Bio、Global Blood Therapeutics、Sangamo Therapeutics、Acceleron Pharma、Arena Pharmaceuticals、Alnylam Pharmaceuticals） ・結論 |
Sickle Cell Disease (SCD) is a group of blood disorders typically inherited from a person’s parents.
The care of people with sickle cell disease may include infection prevention with vaccination and antibiotics, high fluid intake, folic acid supplementation and pain medication.
Market Analysis and Insights: Global Sickle Cell Disease Treatments Market
The global Sickle Cell Disease Treatments market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Sickle Cell Disease Treatments market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Sickle Cell Disease Treatments market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Sickle Cell Disease Treatments market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Sickle Cell Disease Treatments market.
Global Sickle Cell Disease Treatments Scope and Market Size
Sickle Cell Disease Treatments market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Sickle Cell Disease Treatments market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Infection Prevention with Vaccination and Antibiotics
Blood Transfusion
The Medication Hydroxycarbamide
A Transplant of Bone Marrow Cells
Segment by Application
Hospitals
Ambulatory Surgical Centers
Clinics
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
AstraZeneca
Eli Lilly
Bristol-Myers Squibb
Novartis
Pfizer
Baxter
Emmaus Life Sciences
Bluebird Bio
Global Blood Therapeutics
Novartis
Pfizer
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Sickle Cell Disease Treatments Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Infection Prevention with Vaccination and Antibiotics
1.2.3 Blood Transfusion
1.2.4 The Medication Hydroxycarbamide
1.2.5 A Transplant of Bone Marrow Cells
1.3 Market by Application
1.3.1 Global Sickle Cell Disease Treatments Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Clinics
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Sickle Cell Disease Treatments Market Perspective (2016-2027)
2.2 Sickle Cell Disease Treatments Growth Trends by Regions
2.2.1 Sickle Cell Disease Treatments Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Sickle Cell Disease Treatments Historic Market Share by Regions (2016-2021)
2.2.3 Sickle Cell Disease Treatments Forecasted Market Size by Regions (2022-2027)
2.3 Sickle Cell Disease Treatments Industry Dynamic
2.3.1 Sickle Cell Disease Treatments Market Trends
2.3.2 Sickle Cell Disease Treatments Market Drivers
2.3.3 Sickle Cell Disease Treatments Market Challenges
2.3.4 Sickle Cell Disease Treatments Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Sickle Cell Disease Treatments Players by Revenue
3.1.1 Global Top Sickle Cell Disease Treatments Players by Revenue (2016-2021)
3.1.2 Global Sickle Cell Disease Treatments Revenue Market Share by Players (2016-2021)
3.2 Global Sickle Cell Disease Treatments Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Sickle Cell Disease Treatments Revenue
3.4 Global Sickle Cell Disease Treatments Market Concentration Ratio
3.4.1 Global Sickle Cell Disease Treatments Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Sickle Cell Disease Treatments Revenue in 2020
3.5 Sickle Cell Disease Treatments Key Players Head office and Area Served
3.6 Key Players Sickle Cell Disease Treatments Product Solution and Service
3.7 Date of Enter into Sickle Cell Disease Treatments Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Sickle Cell Disease Treatments Breakdown Data by Type
4.1 Global Sickle Cell Disease Treatments Historic Market Size by Type (2016-2021)
4.2 Global Sickle Cell Disease Treatments Forecasted Market Size by Type (2022-2027)
5 Sickle Cell Disease Treatments Breakdown Data by Application
5.1 Global Sickle Cell Disease Treatments Historic Market Size by Application (2016-2021)
5.2 Global Sickle Cell Disease Treatments Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Sickle Cell Disease Treatments Market Size (2016-2027)
6.2 North America Sickle Cell Disease Treatments Market Size by Type
6.2.1 North America Sickle Cell Disease Treatments Market Size by Type (2016-2021)
6.2.2 North America Sickle Cell Disease Treatments Market Size by Type (2022-2027)
6.2.3 North America Sickle Cell Disease Treatments Market Size by Type (2016-2027)
6.3 North America Sickle Cell Disease Treatments Market Size by Application
6.3.1 North America Sickle Cell Disease Treatments Market Size by Application (2016-2021)
6.3.2 North America Sickle Cell Disease Treatments Market Size by Application (2022-2027)
6.3.3 North America Sickle Cell Disease Treatments Market Size by Application (2016-2027)
6.4 North America Sickle Cell Disease Treatments Market Size by Country
6.4.1 North America Sickle Cell Disease Treatments Market Size by Country (2016-2021)
6.4.2 North America Sickle Cell Disease Treatments Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Sickle Cell Disease Treatments Market Size (2016-2027)
7.2 Europe Sickle Cell Disease Treatments Market Size by Type
7.2.1 Europe Sickle Cell Disease Treatments Market Size by Type (2016-2021)
7.2.2 Europe Sickle Cell Disease Treatments Market Size by Type (2022-2027)
7.2.3 Europe Sickle Cell Disease Treatments Market Size by Type (2016-2027)
7.3 Europe Sickle Cell Disease Treatments Market Size by Application
7.3.1 Europe Sickle Cell Disease Treatments Market Size by Application (2016-2021)
7.3.2 Europe Sickle Cell Disease Treatments Market Size by Application (2022-2027)
7.3.3 Europe Sickle Cell Disease Treatments Market Size by Application (2016-2027)
7.4 Europe Sickle Cell Disease Treatments Market Size by Country
7.4.1 Europe Sickle Cell Disease Treatments Market Size by Country (2016-2021)
7.4.2 Europe Sickle Cell Disease Treatments Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Sickle Cell Disease Treatments Market Size (2016-2027)
8.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type
8.2.1 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2016-2027)
8.3 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application
8.3.1 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2016-2027)
8.4 Asia-Pacific Sickle Cell Disease Treatments Market Size by Region
8.4.1 Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Sickle Cell Disease Treatments Market Size (2016-2027)
9.2 Latin America Sickle Cell Disease Treatments Market Size by Type
9.2.1 Latin America Sickle Cell Disease Treatments Market Size by Type (2016-2021)
9.2.2 Latin America Sickle Cell Disease Treatments Market Size by Type (2022-2027)
9.2.3 Latin America Sickle Cell Disease Treatments Market Size by Type (2016-2027)
9.3 Latin America Sickle Cell Disease Treatments Market Size by Application
9.3.1 Latin America Sickle Cell Disease Treatments Market Size by Application (2016-2021)
9.3.2 Latin America Sickle Cell Disease Treatments Market Size by Application (2022-2027)
9.3.3 Latin America Sickle Cell Disease Treatments Market Size by Application (2016-2027)
9.4 Latin America Sickle Cell Disease Treatments Market Size by Country
9.4.1 Latin America Sickle Cell Disease Treatments Market Size by Country (2016-2021)
9.4.2 Latin America Sickle Cell Disease Treatments Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Sickle Cell Disease Treatments Market Size (2016-2027)
10.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type
10.2.1 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2016-2027)
10.3 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application
10.3.1 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2016-2027)
10.4 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country
10.4.1 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Sickle Cell Disease Treatments Introduction
11.1.4 AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Eli Lilly
11.2.1 Eli Lilly Company Details
11.2.2 Eli Lilly Business Overview
11.2.3 Eli Lilly Sickle Cell Disease Treatments Introduction
11.2.4 Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.2.5 Eli Lilly Recent Development
11.3 Bristol-Myers Squibb
11.3.1 Bristol-Myers Squibb Company Details
11.3.2 Bristol-Myers Squibb Business Overview
11.3.3 Bristol-Myers Squibb Sickle Cell Disease Treatments Introduction
11.3.4 Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.3.5 Bristol-Myers Squibb Recent Development
11.4 Novartis
11.4.1 Novartis Company Details
11.4.2 Novartis Business Overview
11.4.3 Novartis Sickle Cell Disease Treatments Introduction
11.4.4 Novartis Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.4.5 Novartis Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Sickle Cell Disease Treatments Introduction
11.5.4 Pfizer Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Baxter
11.6.1 Baxter Company Details
11.6.2 Baxter Business Overview
11.6.3 Baxter Sickle Cell Disease Treatments Introduction
11.6.4 Baxter Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.6.5 Baxter Recent Development
11.7 Emmaus Life Sciences
11.7.1 Emmaus Life Sciences Company Details
11.7.2 Emmaus Life Sciences Business Overview
11.7.3 Emmaus Life Sciences Sickle Cell Disease Treatments Introduction
11.7.4 Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.7.5 Emmaus Life Sciences Recent Development
11.8 Bluebird Bio
11.8.1 Bluebird Bio Company Details
11.8.2 Bluebird Bio Business Overview
11.8.3 Bluebird Bio Sickle Cell Disease Treatments Introduction
11.8.4 Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.8.5 Bluebird Bio Recent Development
11.9 Global Blood Therapeutics
11.9.1 Global Blood Therapeutics Company Details
11.9.2 Global Blood Therapeutics Business Overview
11.9.3 Global Blood Therapeutics Sickle Cell Disease Treatments Introduction
11.9.4 Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.9.5 Global Blood Therapeutics Recent Development
11.10 Sangamo Therapeutics
11.10.1 Sangamo Therapeutics Company Details
11.10.2 Sangamo Therapeutics Business Overview
11.10.3 Sangamo Therapeutics Sickle Cell Disease Treatments Introduction
11.10.4 Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.10.5 Sangamo Therapeutics Recent Development
11.11 Acceleron Pharma
11.11.1 Acceleron Pharma Company Details
11.11.2 Acceleron Pharma Business Overview
11.11.3 Acceleron Pharma Sickle Cell Disease Treatments Introduction
11.11.4 Acceleron Pharma Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.11.5 Acceleron Pharma Recent Development
11.12 Arena Pharmaceuticals
11.12.1 Arena Pharmaceuticals Company Details
11.12.2 Arena Pharmaceuticals Business Overview
11.12.3 Arena Pharmaceuticals Sickle Cell Disease Treatments Introduction
11.12.4 Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.12.5 Arena Pharmaceuticals Recent Development
11.13 Alnylam Pharmaceuticals
11.13.1 Alnylam Pharmaceuticals Company Details
11.13.2 Alnylam Pharmaceuticals Business Overview
11.13.3 Alnylam Pharmaceuticals Sickle Cell Disease Treatments Introduction
11.13.4 Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2016-2021)
11.13.5 Alnylam Pharmaceuticals Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Sickle Cell Disease Treatments Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Infection Prevention with Vaccination and Antibiotics
Table 3. Key Players of Blood Transfusion
Table 4. Key Players of The Medication Hydroxycarbamide
Table 5. Key Players of A Transplant of Bone Marrow Cells
Table 6. Global Sickle Cell Disease Treatments Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Sickle Cell Disease Treatments Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Sickle Cell Disease Treatments Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Sickle Cell Disease Treatments Market Share by Regions (2016-2021)
Table 10. Global Sickle Cell Disease Treatments Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Sickle Cell Disease Treatments Market Share by Regions (2022-2027)
Table 12. Sickle Cell Disease Treatments Market Trends
Table 13. Sickle Cell Disease Treatments Market Drivers
Table 14. Sickle Cell Disease Treatments Market Challenges
Table 15. Sickle Cell Disease Treatments Market Restraints
Table 16. Global Sickle Cell Disease Treatments Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Sickle Cell Disease Treatments Market Share by Players (2016-2021)
Table 18. Global Top Sickle Cell Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatments as of 2020)
Table 19. Ranking of Global Top Sickle Cell Disease Treatments Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Sickle Cell Disease Treatments Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Sickle Cell Disease Treatments Product Solution and Service
Table 23. Date of Enter into Sickle Cell Disease Treatments Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2016-2021)
Table 27. Global Sickle Cell Disease Treatments Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Sickle Cell Disease Treatments Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Sickle Cell Disease Treatments Revenue Market Share by Application (2016-2021)
Table 31. Global Sickle Cell Disease Treatments Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Sickle Cell Disease Treatments Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Sickle Cell Disease Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Sickle Cell Disease Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Sickle Cell Disease Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Sickle Cell Disease Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Sickle Cell Disease Treatments Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Sickle Cell Disease Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Sickle Cell Disease Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Sickle Cell Disease Treatments Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Sickle Cell Disease Treatments Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Sickle Cell Disease Treatments Market Size by Country (2022-2027) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Sickle Cell Disease Treatments Product
Table 66. AstraZeneca Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 67. AstraZeneca Recent Development
Table 68. Eli Lilly Company Details
Table 69. Eli Lilly Business Overview
Table 70. Eli Lilly Sickle Cell Disease Treatments Product
Table 71. Eli Lilly Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 72. Eli Lilly Recent Development
Table 73. Bristol-Myers Squibb Company Details
Table 74. Bristol-Myers Squibb Business Overview
Table 75. Bristol-Myers Squibb Sickle Cell Disease Treatments Product
Table 76. Bristol-Myers Squibb Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 77. Bristol-Myers Squibb Recent Development
Table 78. Novartis Company Details
Table 79. Novartis Business Overview
Table 80. Novartis Sickle Cell Disease Treatments Product
Table 81. Novartis Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 82. Novartis Recent Development
Table 83. Pfizer Company Details
Table 84. Pfizer Business Overview
Table 85. Pfizer Sickle Cell Disease Treatments Product
Table 86. Pfizer Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 87. Pfizer Recent Development
Table 88. Baxter Company Details
Table 89. Baxter Business Overview
Table 90. Baxter Sickle Cell Disease Treatments Product
Table 91. Baxter Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 92. Baxter Recent Development
Table 93. Emmaus Life Sciences Company Details
Table 94. Emmaus Life Sciences Business Overview
Table 95. Emmaus Life Sciences Sickle Cell Disease Treatments Product
Table 96. Emmaus Life Sciences Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 97. Emmaus Life Sciences Recent Development
Table 98. Bluebird Bio Company Details
Table 99. Bluebird Bio Business Overview
Table 100. Bluebird Bio Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 101. Bluebird Bio Recent Development
Table 102. Global Blood Therapeutics Company Details
Table 103. Global Blood Therapeutics Business Overview
Table 104. Global Blood Therapeutics Sickle Cell Disease Treatments Product
Table 105. Global Blood Therapeutics Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 106. Global Blood Therapeutics Recent Development
Table 107. Sangamo Therapeutics Company Details
Table 108. Sangamo Therapeutics Business Overview
Table 109. Sangamo Therapeutics Sickle Cell Disease Treatments Product
Table 110. Sangamo Therapeutics Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 111. Sangamo Therapeutics Recent Development
Table 112. Acceleron Pharma Company Details
Table 113. Acceleron Pharma Business Overview
Table 114. Acceleron Pharma Sickle Cell Disease Treatments Product
Table 115. Acceleron Pharma Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 116. Acceleron Pharma Recent Development
Table 117. Arena Pharmaceuticals Company Details
Table 118. Arena Pharmaceuticals Business Overview
Table 119. Arena Pharmaceuticals Sickle Cell Disease Treatments Product
Table 120. Arena Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 121. Arena Pharmaceuticals Recent Development
Table 122. Alnylam Pharmaceuticals Company Details
Table 123. Alnylam Pharmaceuticals Business Overview
Table 124. Alnylam Pharmaceuticals Sickle Cell Disease Treatments Product
Table 125. Alnylam Pharmaceuticals Revenue in Sickle Cell Disease Treatments Business (2016-2021) & (US$ Million)
Table 126. Alnylam Pharmaceuticals Recent Development
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sickle Cell Disease Treatments Market Share by Type: 2020 VS 2027
Figure 2. Infection Prevention with Vaccination and Antibiotics Features
Figure 3. Blood Transfusion Features
Figure 4. The Medication Hydroxycarbamide Features
Figure 5. A Transplant of Bone Marrow Cells Features
Figure 6. Global Sickle Cell Disease Treatments Market Share by Application: 2020 VS 2027
Figure 7. Hospitals Case Studies
Figure 8. Ambulatory Surgical Centers Case Studies
Figure 9. Clinics Case Studies
Figure 10. Others Case Studies
Figure 11. Sickle Cell Disease Treatments Report Years Considered
Figure 12. Global Sickle Cell Disease Treatments Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 13. Global Sickle Cell Disease Treatments Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 14. Global Sickle Cell Disease Treatments Market Share by Regions: 2020 VS 2027
Figure 15. Global Sickle Cell Disease Treatments Market Share by Regions (2022-2027)
Figure 16. Global Sickle Cell Disease Treatments Market Share by Players in 2020
Figure 17. Global Top Sickle Cell Disease Treatments Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sickle Cell Disease Treatments as of 2020
Figure 18. The Top 10 and 5 Players Market Share by Sickle Cell Disease Treatments Revenue in 2020
Figure 19. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2016-2021)
Figure 20. Global Sickle Cell Disease Treatments Revenue Market Share by Type (2022-2027)
Figure 21. North America Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 22. North America Sickle Cell Disease Treatments Market Share by Type (2016-2027)
Figure 23. North America Sickle Cell Disease Treatments Market Share by Application (2016-2027)
Figure 24. North America Sickle Cell Disease Treatments Market Share by Country (2016-2027)
Figure 25. United States Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Canada Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Sickle Cell Disease Treatments Market Share by Type (2016-2027)
Figure 29. Europe Sickle Cell Disease Treatments Market Share by Application (2016-2027)
Figure 30. Europe Sickle Cell Disease Treatments Market Share by Country (2016-2027)
Figure 31. Germany Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. France Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. U.K. Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Italy Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Russia Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Nordic Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Sickle Cell Disease Treatments Market Share by Type (2016-2027)
Figure 39. Asia-Pacific Sickle Cell Disease Treatments Market Share by Application (2016-2027)
Figure 40. Asia-Pacific Sickle Cell Disease Treatments Market Share by Region (2016-2027)
Figure 41. China Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Japan Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. South Korea Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Southeast Asia Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. India Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Australia Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Sickle Cell Disease Treatments Market Share by Type (2016-2027)
Figure 49. Latin America Sickle Cell Disease Treatments Market Share by Application (2016-2027)
Figure 50. Latin America Sickle Cell Disease Treatments Market Share by Country (2016-2027)
Figure 51. Mexico Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Brazil Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Sickle Cell Disease Treatments Market Share by Type (2016-2027)
Figure 55. Middle East & Africa Sickle Cell Disease Treatments Market Share by Application (2016-2027)
Figure 56. Middle East & Africa Sickle Cell Disease Treatments Market Share by Country (2016-2027)
Figure 57. Turkey Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Saudi Arabia Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. UAE Sickle Cell Disease Treatments Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. AstraZeneca Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 61. Eli Lilly Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 63. Novartis Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 64. Pfizer Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 65. Baxter Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 66. Emmaus Life Sciences Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 67. Bluebird Bio Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 68. Global Blood Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 69. Sangamo Therapeutics Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 70. Acceleron Pharma Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 71. Arena Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 72. Alnylam Pharmaceuticals Revenue Growth Rate in Sickle Cell Disease Treatments Business (2016-2021)
Figure 73. Bottom-up and Top-down Approaches for This Report
Figure 74. Data Triangulation
Figure 75. Key Executives Interviewed
世界の鎌状赤血球症治療市場規模・現状・予測（2021年-2027年） Sickle cell disease is a group of disorders that affects hemoglobin, the molecule in red blood cells that delivers oxygen to cells throughout the body. People with this disorderhave atypical hemoglobin molecules called hemoglobin S, which can distort red blood cells into a sickle, or crescent, shape…- 世界の鎌状赤血球市場規模・現状・予測（2021年-2027年） The global sickle cell market is expected to grow in future due to rising African-American population, economic growth, increasing healthcare expenditure and prevalence of sickle cell. Key trends of this market include progressing drug pipeline and rising research grants. However, there are some fac…
- 世界の鎌状赤血球貧血治療薬市場規模・現状・予測（2021年-2027年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…
- 世界の鎌状赤血球症治療市場 2021：企業別、地域別、種類・用途別 The Sickle Cell Disease Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…
- 世界の鎌状赤血球貧血治療薬市場規模・現状・予測（2021年-2027年） Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglo…